Age, Biography and Wiki

Suzanne L. Topalian was born on 1954 in Alpine, New Jersey, is a physician. Discover Suzanne L. Topalian's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is She in this year and how She spends money? Also learn how She earned most of networth at the age of 69 years old?

Popular As N/A
Occupation N/A
Age 69 years old
Zodiac Sign
Born 1954
Birthday 1954
Birthplace Alpine, New Jersey
Nationality United States

We recommend you to check the complete list of Famous People born on 1954. She is a member of famous physician with the age 69 years old group.

Suzanne L. Topalian Height, Weight & Measurements

At 69 years old, Suzanne L. Topalian height not available right now. We will update Suzanne L. Topalian's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Suzanne L. Topalian's Husband?

Her husband is Drew Pardoll ​(m. 1993)​

Family
Parents Not Available
Husband Drew Pardoll ​(m. 1993)​
Sibling Not Available
Children Not Available

Suzanne L. Topalian Net Worth

Her net worth has been growing significantly in 2022-2023. So, how much is Suzanne L. Topalian worth at the age of 69 years old? Suzanne L. Topalian’s income source is mostly from being a successful physician. She is from United States. We have estimated Suzanne L. Topalian's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income physician

Suzanne L. Topalian Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2018

In 2018, Topalian was appointed the Bloomberg-Kimmel Professor of Cancer Immunotherapy in the Bloomberg-Kimmel Institute for Cancer Immunotherapy. She was also elected to serve on Dragonfly Therapeutics, Inc.'s Scientific Advisory Board.

2015

As the Director of the Melanoma Program, Topalian researches modulating immune checkpoints such as PD-1 and PD-L1 in cancer therapy, and discovering biomarkers predicting clinical outcomes following treatment. In 2015, she was the recipient of the David Karnofsky Memorial Award for her contributions to the research of cancer. The following year, Topalian returned to her original research on Opdivo and found that over one-third of advanced melanoma patients were still alive five years after starting therapy with the cancer drug. While continuing to study human anti-tumor immunity, Topalian was elected to the American Association of Physicians and named the co-recipient of the Taubman Prize Awarded for Ground-Breaking Work in Cancer Immunotherapy. In October 2017, Topalian was elected to the National Academy of Medicine as someone who has "made major contributions to the advancement of the medical sciences, health care and public health."

1989

Upon completing her fellowship at NCI in 1989, Topalian intended to leave but was persuaded to stay and work with tumor immunologist Steven Rosenberg. She remained at the institute's Surgery Branch for 21 years before joining the faculty at Johns Hopkins University to lead the Melanoma Program in the Sidney Kimmel Comprehensive Cancer Center. Her work with the program led to a landmark publication in 2012 showing that nivolumab (Opdivo) produced dramatic responses in people with advanced melanoma and in those with lung cancer. Following this study, Topalian also found that the drug Opdivo caused some patients to have lasting responses that continued even after stopping the drug. She was later named one of Nature's 10 in 2014 for her ability to establish immunotherapy as an important treatment modality in cancer.

1979

Topalian was born to father Malcolm F. Topalian in Alpine, New Jersey. Her father was the president of the Topalian Trading Company, a rug concern in New York. She played piano growing up and won first prize in a Tri-State competition. Upon graduating from high school, Topalian received her undergraduate degree from Wellesley College and her medical degree from Tufts University School of Medicine in 1979. She then completed her residency in general surgery at the Thomas Jefferson University Hospital in Philadelphia under the guidance of Surgical Residency Director Herbert Cohn. Following this, she held two fellowships at both the Children's Hospital of Philadelphia and National Cancer Institute (NCI).

1954

Suzanne Louise Topalian (born 1954) is an American surgical oncologist. She is the Bloomberg-Kimmel Professor of Cancer Immunotherapy in the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University School of Medicine. In this role, she studies human anti-tumor immunity.